Also
U.S. states objected to a plan by Bristol-Myers Squibb Co. and Sanofi-Aventis to keep a generic copy of their top-selling blood thinner Plavix off the market, reviving a dispute over the product’s patent. Attorneys general representing the 50 states had sued Bristol-Myers Squibb on allegations that it misused patents to thwart low-cost rivals.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
